Detailed information for compound 165314

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 455.237 | Formula: C19H18Cl2FNaO6
  • H donors: 2 H acceptors: 4 LogP: 3.98 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: OC(C[C@H](CC(=O)[O-])O)COc1cc(OCc2ccc(cc2)F)c(cc1Cl)Cl.[Na+]
  • InChi: 1S/C19H19Cl2FO6.Na/c20-15-7-16(21)18(28-10-14(24)5-13(23)6-19(25)26)8-17(15)27-9-11-1-3-12(22)4-2-11;/h1-4,7-8,13-14,23-24H,5-6,9-10H2,(H,25,26);/q;+1/p-1/t13-,14?;/m1./s1
  • InChiKey: XTWXMOOCXASKOX-JRLNIEDVSA-M  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus HMG-CoA reductase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Leishmania donovani 3-hydroxy-3-methylglutaryl-CoA reductase, putative Get druggable targets OG5_127955 All targets in OG5_127955
Leishmania infantum 3-hydroxy-3-methylglutaryl-CoA reductase, putative Get druggable targets OG5_127955 All targets in OG5_127955
Candida albicans hydroxymethylglutaryl-CoA reductase (ergosterol biosynthesis) Get druggable targets OG5_127955 All targets in OG5_127955
Schistosoma mansoni hydroxymethylglutaryl-CoA reductase (NADPH) Get druggable targets OG5_127955 All targets in OG5_127955
Schistosoma japonicum ko:K00021 3-hydroxy-3-methylglutaryl-CoA reductase [EC1.1.1.34], putative Get druggable targets OG5_127955 All targets in OG5_127955
Trypanosoma cruzi 3-hydroxy-3-methylglutaryl-CoA reductase, putative Get druggable targets OG5_127955 All targets in OG5_127955
Leishmania major 3-hydroxy-3-methylglutaryl-CoA reductase Get druggable targets OG5_127955 All targets in OG5_127955
Leishmania mexicana 3-hydroxy-3-methylglutaryl-CoA reductase, putative Get druggable targets OG5_127955 All targets in OG5_127955
Trypanosoma congolense 3-hydroxy-3-methylglutaryl-CoA reductase, putative Get druggable targets OG5_127955 All targets in OG5_127955
Mycobacterium ulcerans hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase Get druggable targets OG5_127955 All targets in OG5_127955
Trypanosoma cruzi 3-hydroxy-3-methylglutaryl-CoA reductase Get druggable targets OG5_127955 All targets in OG5_127955
Brugia malayi Hydroxymethylglutaryl-coenzyme A reductase family protein Get druggable targets OG5_127955 All targets in OG5_127955
Echinococcus granulosus hydroxymethylglutaryl coenzyme A reductase Get druggable targets OG5_127955 All targets in OG5_127955
Trypanosoma brucei 3-hydroxy-3-methylglutaryl-CoA reductase, putative Get druggable targets OG5_127955 All targets in OG5_127955
Trypanosoma brucei gambiense 3-hydroxy-3-methylglutaryl-CoA reductase, putative Get druggable targets OG5_127955 All targets in OG5_127955
Echinococcus multilocularis hydroxymethylglutaryl coenzyme A reductase Get druggable targets OG5_127955 All targets in OG5_127955
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_127955 All targets in OG5_127955
Leishmania braziliensis 3-hydroxy-3-methylglutaryl-CoA reductase, putative Get druggable targets OG5_127955 All targets in OG5_127955
Candida albicans hydroxymethylglutaryl-CoA reductase (ergosterol biosynthesis) Get druggable targets OG5_127955 All targets in OG5_127955

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus carbonic anhydrase II 0.0261 0.2294 0.2294
Loa Loa (eye worm) indoleamine 2,3-dioxygenase 0.0572 1 1
Brugia malayi Eukaryotic-type carbonic anhydrase family protein 0.0261 0.2294 0.2294
Schistosoma mansoni carbonic anhydrase II (carbonate dehydratase II) 0.0261 0.2294 0.2294
Schistosoma mansoni hypothetical protein 0.0572 1 1
Trypanosoma cruzi carbonic anhydrase-like protein, putative 0.0261 0.2294 0.5
Schistosoma mansoni hypothetical protein 0.0572 1 1
Echinococcus multilocularis indoleamine 2,3 dioxygenase 2 0.0572 1 1
Plasmodium falciparum carbonic anhydrase 0.0168 0 0.5
Toxoplasma gondii hypothetical protein 0.0168 0 0.5
Loa Loa (eye worm) carbonic anhydrase 3 0.0261 0.2294 0.2294
Leishmania major carbonic anhydrase-like protein 0.0261 0.2294 0.5
Trypanosoma brucei carbonic anhydrase-like protein 0.0261 0.2294 0.5
Brugia malayi Putative carbonic anhydrase 5 precursor 0.0261 0.2294 0.2294
Trypanosoma cruzi carbonic anhydrase-like protein, putative 0.0261 0.2294 0.5
Schistosoma mansoni carbonic anhydrase II (carbonate dehydratase II) 0.0261 0.2294 0.2294
Echinococcus granulosus indoleamine 23 dioxygenase 2 0.0572 1 1
Loa Loa (eye worm) eukaryotic-type carbonic anhydrase 0.0261 0.2294 0.2294
Echinococcus multilocularis carbonic anhydrase II 0.0261 0.2294 0.2294

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 260 nM In vitro inhibition of HMG-CoA reductase in solubilized rat liver. ChEMBL. 1656041
IC50 (binding) = 260 nM In vitro inhibition of HMG-CoA reductase in solubilized rat liver. ChEMBL. 1656041
Relative potency (binding) = 3 Inhibition of HMG-CoA reductase compared to mevinolin. ChEMBL. 1656041
Relative potency (binding) = 3 Inhibition of HMG-CoA reductase compared to mevinolin. ChEMBL. 1656041

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.